Aspirin Use for Secondary Prevention Amid Negative Messaging in Patients With Cardiovascular Disease

No abstractJAMA Netw Open. 2026 Jun 1;9(6):e2616605. doi: 10.1001/jamanetworkopen.2026.16605.NO ABSTRACTPMID:42241004 | DOI:10.1001/jamanetworkopen.2026.16605

J Jeremy R Van't Hof

Investments in Childhood Community Resources and Subsequent Adult Health Outcomes

JAMA Netw Open. 2026 Jun 1;9(6):e2616711. doi: 10.1001/jamanetworkopen.2026.16711.ABSTRACTIMPORTANCE: Community resources may benefit children's long-term health, but the lasting impact of public spending in childhood is unclear. Identifying policies to address residential wealth and opportunity dis

J Jaime La Charite

Skin Application of Inflammasome Inhibitor MCC950 Prevents Psoriasis-like Cutaneous Manifestations and Associated Systemic Inflammation

Inflammation. 2026 Jun 4. doi: 10.1007/s10753-026-02535-1. Online ahead of print.ABSTRACTPsoriasis is a chronic, systemic inflammatory disease associated with cardiovascular and metabolic comorbidities. It is driven by a sustained immune response in the skin, orchestrated by keratinocytes and both i

C Chiara Terranova

Bridging the gap: adapting heart failure guidelines for resource-limited settings: A European Journal of Heart Failure expert consensus document

Eur J Heart Fail. 2026 Jun 4:xuag142. doi: 10.1093/ejhf/xuag142. Online ahead of print.ABSTRACTHeart failure (HF) remains a leading cause of morbidity and mortality worldwide, with particularly poor outcomes in low- and middle-income countries (LMICs). Despite strong evidence for guideline-directed

A Amr Abdin

Peak cardiorespiratory and metabolic responses during the six-minute stepper test in people with COPD: A pre-planned cross-sectional ancillary study

Pulmonology. 2026 Dec;32(1):2683324. doi: 10.1080/25310429.2026.2683324. Epub 2026 Jun 4.ABSTRACTBACKGROUND: The six-minute stepper test (6MST) is increasingly used to assess functional exercise capacity in people with chronic obstructive pulmonary disease (COPD). However, the physiological response

A Arthur Hinfray

Embedding patient-reported outcomes in cardiovascular care and research

No abstractEur Heart J. 2026 Jun 4:ehag169. doi: 10.1093/eurheartj/ehag169. Online ahead of print.NO ABSTRACTPMID:42240852 | DOI:10.1093/eurheartj/ehag169

E Elena Arbelo

Comment on "Polypill Strategy: A Paradigm Shift in Cardiovascular Disease Prevention"

No abstractAm J Cardiovasc Drugs. 2026 Jun 4. doi: 10.1007/s40256-026-00804-w. Online ahead of print.NO ABSTRACTPMID:42240818 | DOI:10.1007/s40256-026-00804-w

F Frank A Snyder

Diagnostic performance of lung ultrasound for systemic sclerosis-associated interstitial lung disease: an international cross-sectional study from two tertiary care centers

Clin Rheumatol. 2026 Jun 4. doi: 10.1007/s10067-026-08191-y. Online ahead of print.ABSTRACTOBJECTIVE: To assess the diagnostic accuracy of two lung ultrasound (LUS) scores (≥ 10 B-lines and pleural line abnormalities according to Fairchild's criteria) for detecting interstitial lung disease (ILD) in

D Davide Mohammad Reza Beigi

Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational study

Clin Rheumatol. 2026 Jun 4. doi: 10.1007/s10067-026-08175-y. Online ahead of print.ABSTRACTOBJECTIVE: To evaluate real-world treatment maintenance, effectiveness, and safety of Janus kinase inhibitors (JAKi) in rheumatoid arthritis (RA), and to assess changes in prescribing patterns following the Oc

S Salomé Abdellaoui

Baicalin attenuates angiotensin II-induced vascular endothelial injury via targeted activation of the Nrf2 signaling pathway: Integrated computational and in vitro evidence

Mol Divers. 2026 Jun 4. doi: 10.1007/s11030-026-11602-6. Online ahead of print.ABSTRACTAngiotensin II (AngII)-mediated oxidative stress is a primary driver of vascular endothelial dysfunction, a critical pathogenesis in hypertension and cardiovascular diseases. While baicalin is recognized for its c

D Dongli Zhang

Infliximab as an Effective Second-Line Treatment for IVIG-Resistant Kawasaki Disease Accompanied by Severe Dyslipidemia

Pediatr Cardiol. 2026 Jun 4. doi: 10.1007/s00246-026-04323-y. Online ahead of print.ABSTRACTFor high-dose intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD), individualized selection of second-line therapy according to clinical subgroups could be useful to prevent progression of coron

Y Yuto Sunaga

Camellia diacylglycerol oil attenuates atherosclerosis and NAFLD by modulating gut microbiota and lipid metabolism in ApoE-/- mice

J Sci Food Agric. 2026 Jun 4. doi: 10.1002/jsfa.70776. Online ahead of print.ABSTRACTBACKGROUND: Camellia diacylglycerol oil (CDO), produced by enzymatic glycerolysis of camellia oil, is widely consumed as a functional food ingredient; however, its cardiovascular benefits remain insufficiently chara

S Sihua Wang

Vascular smooth muscle cell mechanotransduction: Pathways, phenotypes and emerging technologies

J Physiol. 2026 Jun 4. doi: 10.1113/JP290371. Online ahead of print.ABSTRACTVascular smooth muscle cells (VSMCs) are the predominant cell type of the tunica media and are central mediators of vascular wall integrity, governing tone, remodelling and the progression of arterial disease. Despite this,

N Nivethitha Kota Lakshminaraasimulu

Transient Left Ventricular Dysfunction in Loeys-Dietz Syndrome With Loss-of-Function TGFBR1 Variants

JACC Case Rep. 2026 Jun 3:108608. doi: 10.1016/j.jaccas.2026.108608. Online ahead of print.ABSTRACTBACKGROUND: Loeys-Dietz syndrome (LDS) is an autosomal dominant connective tissue disorder characterized by vascular and valvular diseases. TGFBR1 is a major causative gene, mediating disease progressi

Y Yuna Hirota

Association between Impaired Lung Function and Pulmonary Perfusion Defects Assessed by Phase-resolved Functional Lung MRI

Radiol Cardiothorac Imaging. 2026 Jun;8(3):e250334. doi: 10.1148/ryct.250334.ABSTRACTPurpose To investigate the association between impaired lung function and pulmonary perfusion defect percentage (QDP) using phase-resolved functional lung (PREFUL) MRI. Materials and Methods In this prospective stud

T Tao Ouyang

Incidence and Outcomes of Refractory Septic Shock per Consensus Clinical Criteria: A Multicohort Retrospective Study

Crit Care Med. 2026 Jun 4. doi: 10.1097/CCM.0000000000007234. Online ahead of print.ABSTRACTOBJECTIVES: Consensus clinical criteria for refractory septic shock were recently developed, but the incidence and outcomes with these criteria are unknown. There were two aims: 1) to describe the incidence o

S Seth R Bauer

Prevalence and related factors of blood pressure regulation abnormalities in Parkinson's disease: Orthostatic hypotension and supine hypertension

J Parkinsons Dis. 2026 Jun 4:1877718X261457798. doi: 10.1177/1877718X261457798. Online ahead of print.ABSTRACTBackgroundOrthostatic hypotension (OH) and supine hypertension (SH) are common in patients with Parkinson's disease (PD), contributing to disease-related morbidity and mortality. However, in

J Jinyu Jia

From Transseptal Puncture to Mitral Commissurotomy: A Zero-Wire-Exchange Approach Using Inoue Balloon

JACC Case Rep. 2026 Jun 3;31(22):108027. doi: 10.1016/j.jaccas.2026.108027.ABSTRACTPercutaneous mitral commissurotomy (PMC) remains the standard therapy for rheumatic mitral stenosis, although decreasing disease prevalence in developed countries has reduced operator familiarity. Advancing the Inoue

H Hossameldin Hussein

Severe Mitral Regurgitation Triggered by Myocardial Ischemia in Hypertrophic Cardiomyopathy With Abnormalities of the Mitral Valve Complex

JACC Case Rep. 2026 Jun 3;31(22):108043. doi: 10.1016/j.jaccas.2026.108043.ABSTRACTBACKGROUND: Mitral regurgitation (MR) is a common complication of hypertrophic cardiomyopathy. Clarifying the etiology is essential for its management.CASE SUMMARY: A 73-year-old man with hypertrophic obstructive card

T Terumori Satoh

Left Ventricular Assist Device Implantation and Aneurysmectomy for a Giant Left Ventricular Aneurysm

JACC Case Rep. 2026 Jun 3;31(22):107954. doi: 10.1016/j.jaccas.2026.107954.ABSTRACTBACKGROUND: Implanting a left ventricular assist device (LVAD) for end-stage heart failure with a giant left ventricular aneurysm is challenging, primarily owing to risks of unstable anchoring and inflow malalignment.

W Wenjun Yu

Convalescent Spontaneous Coronary Artery Dissection With Elevated Pericoronary Fat Attenuation Index

JACC Case Rep. 2026 Jun 3;31(22):108128. doi: 10.1016/j.jaccas.2026.108128.ABSTRACTBACKGROUND: Myocardial infarction with nonobstructive coronary arteries (MINOCA) is defined by the presence of the universal acute myocardial infarction criteria in the absence of obstructive disease on angiography. M

A Alec L Sinatro

Lipoprotein(a) and residual cardiovascular risk in statin-treated patients

Eur J Prev Cardiol. 2026 Jun 4:zwag296. doi: 10.1093/eurjpc/zwag296. Online ahead of print.ABSTRACTAIMS: This study assessed the risk associated with moderately elevated lipoprotein(a) (Lp[a]) levels below current thresholds in a statin-treated population and explored possible differences in the eff

S Sam-Lennart Oftadeh

Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial

JAMA. 2026 Jun 4. doi: 10.1001/jama.2026.9379. Online ahead of print.ABSTRACTIMPORTANCE: Approximately 10% to 15% of patients with advanced chronic kidney disease (CKD) experience a fatal or nonfatal cardiovascular event annually. The effects of antithrombotic therapies on cardiovascular events in p

S Sunil V Badve

Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: Research Summary

No abstractJAMA. 2026 Jun 4:e269463. doi: 10.1001/jama.2026.9463. Online ahead of print.NO ABSTRACTPMID:42240161 | DOI:10.1001/jama.2026.9463